Asia Pacific News Journal
SEE OTHER BRANDS

The top news stories from Asia and the Pacific

Asia Pacific News Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific News Journal.

Press releases published on April 28, 2025

Future Food Asia announces 10 groundbreaking AgriFoodTech startup finalists competing for the USD 100,000 FFA Award 2025

Future Food Asia announces 10 groundbreaking AgriFoodTech startup finalists competing for the USD 100,000 FFA Award 2025

SINGAPORE, April 28, 2025 /⁨EINPresswire.com⁩/ -- Returning for its 9th edition, Future Food Asia, the premier platform celebrating innovation in AgriFoodtech in APAC, is proud to unveil the 10 startups selected for the finale of its annual competition. …

Dr. Sud Agarwal and iNGENū CRO Lead Asia-Pacific in Complex Trials for Profound Neurodevelopmental Disorders

Dr. Sud Agarwal and iNGENū CRO Lead Asia-Pacific in Complex Trials for Profound Neurodevelopmental Disorders

Dr. Sud Agarwal and iNGENū CRO Lead Asia-Pacific in Complex Trials for Profound Neurodevelopmental Disorders MELBOURNE, AUSTRALIA, April 28, 2025 /⁨EINPresswire.com⁩/ -- iNGENū CRO, a full-service contract research organization headquartered in Australia, …

Honeygain Partners with Tipalti to Enhance Global Payout Experience

Honeygain Partners with Tipalti to Enhance Global Payout Experience

Honeygain partners with Tipalti to streamline global payouts, making it easier for users to earn by sharing their internet connection. LONDON, UNITED KINGDOM, April 28, 2025 /⁨EINPresswire.com⁩/ -- Honeygain, the first-ever app that allows its users to …

Ayushman Skin & Cosmetology Clinic Launches Online Booking Service for Convenient Access to Face and Hair Treatments

Ayushman Skin & Cosmetology Clinic Launches Online Booking Service for Convenient Access to Face and Hair Treatments

NEW DELHI, DWARKA, INDIA, April 28, 2025 /⁨EINPresswire.com⁩/ -- Ayushman Skin …

IT Managed Services Market CAGR 9.44 % with Growth USD 650.25 billion Billion by 2033

IT Managed Services Market CAGR 9.44 % with Growth USD 650.25 billion Billion by 2033

Top major players in the IT Managed Services industry, including.Dell EMC, Presidio, IBM, DXC Technology, CenturyLink, Accenture, SAS Institute, Cognizant PUNE, MAHARASHTRA, INDIA, April 28, 2025 /⁨EINPresswire.com⁩/ -- "IT Managed Services Market" …

Cellectis présente une approche non virale d’édition du génome et des innovations avec les base editors à l’ASGCT 2025

Cellectis présente une approche non virale d’édition du génome et des innovations avec les base editors à l’ASGCT 2025

NEW YORK, 28 avr. 2025 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS - NASDAQ : CLLS) (la "Société"), société de biotechnologie de stade clinique, qui utilise sa technologie pionnière d'édition de génome pour développer des thérapies cellulaires …

Trident Filed 2024 Annual Report on Form 20-F

Trident Filed 2024 Annual Report on Form 20-F

SINGAPORE, April 29, 2025 (GLOBE NEWSWIRE) -- Trident Digital Tech Holdings Ltd (“Trident” or the “Company,” NASDAQ: TDTH), a leading catalyst for digital transformation in technology optimization services and Web 3.0 activation based in Singapore, today …

Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting

Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting

PHILADELPHIA, April 28, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today …

CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting

CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting

Preclinical data to showcase the potential of regRNA-targeting to increase protein levels in a clinically meaningful way by upregulating gene expression Interim safety data including patient demographic data from all SAD cohorts of the first-in-human Phase …

Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting

Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today unveils …

Phoenix Asia Holdings Limited Announces Closing of Its Initial Public Offering

Phoenix Asia Holdings Limited Announces Closing of Its Initial Public Offering

Hong Kong, April 28, 2025 (GLOBE NEWSWIRE) -- Phoenix Asia Holdings Limited (the “Company” or “PHOE”), a premier substructure contractor for public and private sector projects in Hong Kong, today announced the closing of its initial public offering (the “ …

Terra Balcanica annonce un placement fondé sur la dispense pour financement de l’émetteur coté

Terra Balcanica annonce un placement fondé sur la dispense pour financement de l’émetteur coté

NE PAS DIFFUSER AUX ÉTATS-UNIS OU PAR L’INTERMÉDIAIRE DES SERVICES D’INFORMATION DES ÉTATS-UNIS Vancouver, Colombie-Britannique, 28 avr. 2025 (GLOBE NEWSWIRE) -- Terra Balcanica Resources Corp. (« Terra » ou la « Société ») (CSE : TERA; FRA : UB1) a le …

Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences

Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences

NEW HOPE, Pa., April 28, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today …

Ebang International Reports Financial Results for Fiscal Year 2024

Ebang International Reports Financial Results for Fiscal Year 2024

SINGAPORE, April 28, 2025 (GLOBE NEWSWIRE) -- Ebang International Holdings Inc. (Nasdaq: EBON, the “Company,” “we” or “our”), today announced its financial results for the fiscal year ended December 31, 2024. Operational and Financial Highlights for Fiscal …

Powell Max Limited Announces 2024 Audited Financial Results

Powell Max Limited Announces 2024 Audited Financial Results

HONG KONG, April 28, 2025 (GLOBE NEWSWIRE) -- Powell Max Limited (Nasdaq: PMAX) (the “Company” or “Powell Max”), a financial communications services provider headquartered in Hong Kong, today announced the audited financial results of the Company and its …

Two Senior Executives Join the Diginex Team to Drive Sustainable Finance Initiatives and strategic M&A

Two Senior Executives Join the Diginex Team to Drive Sustainable Finance Initiatives and strategic M&A

LONDON, April 28, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex”) (NASDAQ: DGNX), a leading impact technology company focused on solving pressing environmental, social, and governance (ESG) challenges, is thrilled to announce the appointment of two …

Relay Therapeutics to Announce First Quarter 2025 Financial Results and Corporate Highlights on May 5, 2025

Relay Therapeutics to Announce First Quarter 2025 Financial Results and Corporate Highlights on May 5, 2025

CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, will …

Foghorn Therapeutics Presents New Preclinical Data on Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Programs and Provides Pipeline Update

Foghorn Therapeutics Presents New Preclinical Data on Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Programs and Provides Pipeline Update

- FHD-909 (LY4050784) advancing in Phase 1 trial in SMARCA4 (BRG1) mutated cancers, with non-small cell lung cancer (NSCLC) as the primary target population - Preclinical synergistic anti-tumor activity of FHD-909 in combination with pembrolizumab and KRAS …

CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates

CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates

SINGAPORE, April 28, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel …

Tempest Presents New Amezalpat MOA Data Reinforcing Its Potential as Novel Cancer Treatment at the 2025 AACR Annual Meeting

Tempest Presents New Amezalpat MOA Data Reinforcing Its Potential as Novel Cancer Treatment at the 2025 AACR Annual Meeting

BRISBANE, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced that a presentation …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service